Overview


According to FutureWise analysis the market for Adiponectin Testing is expected to register a CAGR of 8.10% from 2023-2031.

Adiponectin, a vital hormone and adipokine protein, exerts a multifaceted influence on a range of metabolic functions within the body, with its most prominent role being in enhancing insulin sensitivity and mitigating inflammation. The chief source of adiponectin production resides within the adipose tissue or body fat. Adipokines, alternatively referred to as adipocytokines, constitute a category of hormones synthesized by adipose tissue, imbued with significant roles in energic and metabolic functions. These metabolic processes, collectively termed metabolism, encompass an array of chemical reactions occurring within the body that facilitate the conversion of ingested calories into usable energy, subsequently distributing this energy to all cellular components.

Adiponectin levels are intricately regulated by insulin-like growth factors and growth hormones, in addition to being significantly influenced by leptin, an adipokine with a pivotal role in adiponectin regulation. The multifaceted functions attributed to adiponectin encompass metabolic and cellular activities, prominently featuring insulin sensitization and anti-inflammatory effects. Its position in modulating insulin sensitivity includes a range of mechanisms: it encourages increased insulin secretion from the pancreas, inhibits glucose production in the liver, stimulates the oxidation of fatty acids, and facilitates glucose intake, while also enhancing insulin-stimulated glucose absorption within adipose tissues. The assessment of adiponectin levels is achieved through a blood test, which provides insight into its concentration. It's important to note that quantifying adiponectin levels may exhibit variations contingent on different laboratories and individual body mass indices (BMI). For individuals with a BMI below 25, the normal range of adiponectin falls within 5-37 mcg/ml (micrograms per milliliter); for those with a BMI between 25 and 30, the content is 4-28 mcg/ml; and for individuals with a BMI exceeding 30, the expected adiponectin level ranges from 4-22 mcg/ml.

FutureWise Market Research has published a report that provides an insightful analysis of Adiponectin Testing Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Adiponectin Testing Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Eagle Biosciences
  • Boster Biological Technology
  • Merck KGaA
  • Merck
  • Thermo fisher Scientific Inc.
  • Biorad Laboratories
  • Stratech

(Note: The list of the major players will be updated with the latest market scenario and trends)

The global surge in obesity rates is closely intertwined with the escalating disposable income of individuals, anticipated to result in heightened food consumption. A discernible trend has emerged, reflecting an increasing inclination towards processed, canned, fried, and baked foods, contributing to a burgeoning calorie intake. This dietary shift, a sedentary lifestyle, and an excessive caloric surplus predispose a significant portion of the population to obesity. Adopting habits involving consuming junk food, pre-packaged meals, and offerings from external food vendors, characterized by their liberal use of calorie-dense components like oils, spices, and cheese, contributes to this alarming health concern. Notably, adiponectin, an essential regulatory hormone, is diminished among those grappling with obesity. 

However, amidst these promising prospects lie substantial challenges. Scarce accessibility of adiponectin testing kits hampers comprehensive diagnostics in economically disadvantaged nations, exacerbating a deficiency in robust medical and healthcare services. This shortage in resources impedes the overall growth potential of the market. Furthermore, the domain demands substantial initial investments, while alternative testing markers coexist in the market, necessitating strategic differentiation for sustainable progress.

By Product Type

  • Adiponectin ELISA Kits
  • Adiponectin Enzyme Immunoassay Kits
  • Others

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America has emerged as a significant driving force behind the robust expansion of the worldwide market. This notable contribution can be primarily attributed to the escalating prospects of adipose-based commodities in fortifying the pharmaceutical pipelines dedicated to treating metabolic syndrome. Concurrently, countries within the Asian region, characterized by a burgeoning medical tourism sector, have been quick to recognize and tap into a particularly auspicious potential within this realm. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Adiponectin Testing Market By Product Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Adiponectin Testing Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Adiponectin Testing Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Adiponectin Testing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Adiponectin Testing Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Adiponectin ELISA Kits
        2. Adiponectin Enzyme Immunoassay Kits
        3. Others

  • 8.   Global Adiponectin Testing Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Diagnostic Laboratories
        3. Research Laboratories

  • 9.   North America Adiponectin Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Adiponectin Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Adiponectin Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Adiponectin Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Eagle Biosciences
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Boster Biological Technology
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merck KGaA
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Merck
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Thermo fisher Scientific Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Biorad Laboratories
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Stratech
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients